Have a personal or library account? Click to login
Movement Disorders in COVID-19: Whither Art Thou? Cover

Movement Disorders in COVID-19: Whither Art Thou?

Tremor and Other Hyperkinetic Movements
Volume 10 (2020): Issue 0
By: Howard L. Geyer,  David M. Kaufman,  Raminder K. Parihar and  Mark F. Mehler  
Open Access
|Aug 2020

References

  1. 1Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients [published online ahead of print April 4, 2020]. J Med Virol. 2020; 92: 552–555. DOI: 10.1002/jmv.25728
    Back to article
  2. 2Román GC, Spencer PS, Reis J, Buguet A, Faris MEA, Katrak SM, et al. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. J Neurol Sci. 2020; 414: 116884. DOI: 10.1016/j.jns.2020.116884
    Back to article
  3. 3Glass WG, Subbarao K, Murphy B, Murphy PM. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol. 2004; 173: 4030–4039. DOI: 10.4049/jimmunol.173.6.4030
    Back to article
  4. 4Yashavantha Rao HC, Jayabaskaran C. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients. J Med Virol. 2020; 92: 786–790. DOI: 10.1002/jmv.25918
    Back to article
  5. 5Tsai LK, Hsieh ST, Chang YC. Neurological manifestations in severe acute respiratory syndrome. Acta Neurol Taiwan. 2005; 14: 113–119.
    Back to article
  6. 6Hoffman LA, Vilensky JA. Encephalitis lethargica: 100 years after the epidemic. Brain. 2017; 40: 2246–2251. DOI: 10.1093/brain/awx177
    Back to article
  7. 7Vilensky JA, Goetz CG, Gilman S. Movement disorders associated with encephalitis lethargica: A video compilation. Mov Disord. 2006; 21: 1–8. DOI: 10.1002/mds.20722
    Back to article
  8. 8Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020; 94: 55–58. DOI: 10.1016/j.ijid.2020.03.062
    Back to article
  9. 9Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19 [published online ahead of print, 2020 Apr 10]. Brain Behav Immun. 2020; S0889–1591(20)30465-7. DOI: 10.1016/j.bbi.2020.04.017
    Back to article
  10. 10Rábano-Suárez P, Bermejo-Guerrero L, Méndez-Guerrero A, Parra-Serrano J, Toledo-Alfocea D, Sánchez-Tejerina D, et al. Generalized myoclonus in COVID-19. Neurology. 2020. DOI: 10.1212/WNL.0000000000009829
    Back to article
  11. 11Khoo A, McLoughlin B, Cheema S, Weil RS, Lambert C, Manji H, et al. Postinfectious brainstem encephalitis associated with SARS-CoV-2 [published online ahead of print, 2020 Jul 7]. J Neurol Neurosurg Psychiatry. 2020; jnnp-2020-323816. DOI: 10.1136/jnnp-2020-323816
    Back to article
  12. 12Méndez-Guerrero A, Laespada-García MI, Gómez-Grande A, Ruiz-Ortiz M, Blanco-Palmero VA, Azcarate-Diaz FJ, et al. Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology. 2020. DOI: 10.1212/WNL.0000000000010282
    Back to article
  13. 13Diezma-Martín AM, Morales-Casado MI, García-Alvarado N, Vadillo Bermejo A, López-Ariztegui N, Sepúlveda Berrocal MA. Tremor and ataxia in COVID-19. Temblor y ataxia en COVID-19. Neurologia. 2020; 35: 409–410. DOI: 10.1016/j.nrl.2020.06.005
    Back to article
  14. 14Joglar B, Rodriguez-Pallares J, Rodriguez-Perez AI, Rey P, Guerra MJ, Labandeira-Garcia JL. The inflammatory response in the MPTP model of Parkinson’s disease is mediated by brain angiotensin: Relevance to progression of the disease. J Neurochem. 2009; 109: 656–669. DOI: 10.1111/j.1471-4159.2009.05999.x
    Back to article
  15. 15Rodriguez-Perez AI, Garrido-Gil P, Pedrosa MA, Garcia-Garrote M, Valenzuela R, Navarro G, et al. Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra. Brain Behav Immun. 2020; 87: 256–271. DOI: 10.1016/j.bbi.2019.12.011
    Back to article
  16. 16Coomes EA, Haghbayan H. Interleukin-6 in COVID-19: A systematic review and meta-analysis. medRxiv. 2020.03.30.20048058; DOI: 10.1101/2020.03.30.20048058
    Back to article
  17. 17Nataf S. An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19. J Med Virol. 2020. DOI: 10.1002/jmv.25826
    Back to article
  18. 18Beattie GC, Glaser CA, Sheriff H, Messenger S, Preas CP, Shahkarami M, et al. Encephalitis with thalamic and basal ganglia abnormalities: Etiologies, neuroimaging, and potential role of respiratory viruses. Clin Infect Dis. 2013; 56: 825–832. DOI: 10.1093/cid/cis990
    Back to article
  19. 19Fishman PS, Gass JS, Swoveland PT, Lavi E, Highkin MK, Weiss SR. Infection of the basal ganglia by a murine coronavirus. Science. 1985; 229: 877–879. DOI: 10.1126/science.2992088
    Back to article
  20. 20Fazzini E, Fleming J, Fahn S. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson’s disease. Mov Disord. 1992; 7: 153–158. DOI: 10.1002/mds.870070210
    Back to article
  21. 21Simmons G, Reeves JD, Rennekamp AJ, Amberg SM, Piefer AJ, Bates P. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci U S A. 2004; 101: 4240–4245. DOI: 10.1073/pnas.0306446101
    Back to article
DOI: https://doi.org/10.5334/tohm.553 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Jul 16, 2020
Accepted on: Jul 21, 2020
Published on: Aug 12, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
SARS-CoV-2,
movement disorders,
encephalitis

© 2020 Howard L. Geyer, David M. Kaufman, Raminder K. Parihar, Mark F. Mehler, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 10 (2020): Issue 0Next article